Washington: India’s Ambassador to America Taranjit Singh Sandhu informed that America has removed the Defense Production Act which means no more priority supply will now be required. This will further smoothen the supply chains for vaccine manufacturing, particularly for AstraZeneca & Novax.
The move would let companies take their own decision on whom they want to sell their vaccines.